bullish
China & HK Strategy: Time for The "Dogs" To Revenge?
284 Views25 Sep 2024 07:30
The stocks that performed poorly in 2023, like Li Ning, Meituan, Wuxi Biologics, and Zhongsheng, are showing a sharp rebound in the last month, with further potential gains from improving sentiment.
What is covered in the Full Insight:
- Introduction
- Overview of 2023 Performance
- Detailed Analysis of Key Stocks
- Future Prospects
- Conclusion
Boomeranged on Fri, 27 Sep 2024 09:17
The "Dogs" surged more significantly than the HSI in the last two days. On average, their share price rose by 10.6%, outperforming the Index by 5.7pp. Instead, the widely overweighted names like China Unicom, CNOOC, and CLP Holdings have come down by an average of 4%. We believe the catch-up of the four names in this Insight will continue as interest reverts to those underperforming this year.
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 3-minute read)
Discussions
(Paid Plans Only)
Rising
Osbert Tang, CFA
HK/China Equity Long-Short
- China & HK Strategy: Time for The "Dogs" To Revenge?25 Sep 2024
- "Buy the Worst" HSI Strategy: A Tragic 2023 and What About 2024?29 Dec 2023
- China Strategy: Are We Still Going to Have January Effect in 2024?15 Dec 2023
x